John Berry Haycraft

Важность для гирудотерапии

John Berry Haycraft's 1884 isolation of hirudin from medicinal leech salivary glands is the single most important event in the molecular history of hirudotherapy. Before Haycraft, the leech was a folk-medicine instrument whose action was attributed to vague 'humoral' or mechanical effects. By demonstrating that a specific chemical secretion was responsible for the prolonged bleeding observed after a leech bite — and that this secretion could be extracted, concentrated, and applied to blood in vitro — Haycraft transformed hirudotherapy from empirical practice into experimental pharmacology. His methodological choice mattered as much as his discovery. Haycraft used Edinburgh's then-novel saline-perfusion technique to flush the leech's anterior salivary glands, then tested the extract against fibrinogen-rich plasma. The resulting non-clotting phenomenon was reproducible, dose-dependent, and species-specific. He correctly inferred (without understanding thrombin) that the active principle interfered with the final step of fibrin formation. Modern crystallographic work — Stone & Hofsteenge in 1986, the PDB structures 1HRT and 4HTC — confirmed Haycraft's intuition with atomic precision: hirudin binds thrombin's active and exosite-1 surfaces with sub-picomolar affinity. Hirudin seeded an entire anticoagulant drug class. Two recombinant hirudin analogs reached the clinic — desirudin (FDA-approved, marketed) and lepirudin (approved 1998, voluntarily withdrawn in 2012) — and the rationally designed synthetic peptide bivalirudin (marketed) was built directly on hirudin's bivalent thrombin-binding architecture. Later synthetic small-molecule inhibitors such as dabigatran were inspired by the same thrombin-inhibition principle Haycraft uncovered, not derived from hirudin itself. The American Society of Hirudotherapy considers him the patron of evidence-based leech medicine — a 19th-century scientist whose careful protocols made it impossible for later generations to dismiss leech therapy as superstition.